Omeros (NASDAQ: OMER) grants director 30,000 options at $13.71
Rhea-AI Filing Summary
OMEROS CORP (OMER) reported that director Joseph L. Schocken received a grant of 30,000 stock options to purchase common stock. The options have an exercise price of $13.71 per share and expire on August 11, 2036. They vest in equal annual installments over three years beginning on the first anniversary of the grant date, and following this grant he holds 30,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Schocken Joseph L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 30,000 shares (Direct)
Footnotes (1)
- F1. This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant.
Key Figures
Stock options granted: 30,000 shares
Exercise price: $13.71 per share
Expiration date: 2036-08-11
+2 more
5 metrics
Stock options granted
30,000 shares
Stock Option (Right to Buy) grant on 2026-08-12
Exercise price
$13.71 per share
Conversion or exercise price of the stock options
Expiration date
2036-08-11
Option expiration for the Stock Option (Right to Buy)
Underlying shares
30,000 shares
Common Stock underlying the granted options
Shares following transaction
30,000 derivative securities
Total derivative securities held directly after grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, derivative securities
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 13.7100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"option shall vest and become exercisable in equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative securities financial
"total_shares_following_transaction: 30000.0000 derivative securities"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did OMER (Omeros Corp) disclose about Joseph L. Schocken in this Form 4?
Omeros Corp reported that director Joseph L. Schocken received a grant of 30,000 stock options to buy common stock. The options were awarded at an exercise price of $13.71 per share, with vesting over three years and expiration in 2036.
What is the size of the stock option grant to Joseph L. Schocken at OMER?
The grant to Joseph L. Schocken consists of 30,000 stock options for Omeros Corp common stock. Each option carries an exercise price of $13.71 per share, and the entire grant represents 30,000 underlying shares if fully exercised.
What is the exercise price and expiration date of Joseph L. Schocken’s OMER options?
The options granted to Joseph L. Schocken have an exercise price of $13.71 per share and expire on August 11, 2036. These terms define the price he must pay to acquire shares and the last date he can exercise the options.
How do Joseph L. Schocken’s OMER stock options vest?
The options vest in equal annual installments over three years, starting on the first anniversary of the grant date. This means one-third of the 30,000 options becomes exercisable each year during the three-year vesting period.
How many OMER derivative securities does Joseph L. Schocken hold after this transaction?
Following this grant, Joseph L. Schocken holds 30,000 derivative securities related to Omeros Corp common stock. These derivatives are the newly granted stock options, each representing the right to purchase one share at the set exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
